CBIZ (NYSE:CBZ - Get Free Report) released its quarterly earnings data on Tuesday. The business services provider reported $0.84 EPS for the quarter, beating the consensus estimate of $0.76 by $0.08, Briefing.com reports. CBIZ had a return on equity of 14.58% and a net margin of 7.12%. The company had revenue of $438.90 million for the quarter, compared to analyst estimates of $440.16 million. During the same period last year, the company posted $0.66 earnings per share. The firm's revenue was up 6.9% compared to the same quarter last year. CBIZ updated its FY 2024 guidance to 2.640-2.690 EPS and its FY24 guidance to $2.64-$2.69 EPS.
CBIZ Stock Down 0.3 %
Shares of CBIZ stock traded down $0.19 on Wednesday, hitting $70.88. 418,522 shares of the company's stock traded hands, compared to its average volume of 314,477. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.43. The firm's 50-day moving average is $67.89 and its 200 day moving average is $72.86. The stock has a market cap of $3.56 billion, a P/E ratio of 30.42 and a beta of 0.92. CBIZ has a 52-week low of $51.16 and a 52-week high of $86.36.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on CBZ. StockNews.com downgraded shares of CBIZ from a "hold" rating to a "sell" rating in a research report on Thursday, September 5th. Sidoti raised shares of CBIZ from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $80.00 to $86.00 in a research note on Monday, August 12th.
View Our Latest Stock Analysis on CBIZ
CBIZ Company Profile
(
Get Free Report)
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Featured Stories
Before you consider CBIZ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CBIZ wasn't on the list.
While CBIZ currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.